Presbyopia Eye Drop From Startup Tenpoint Gets FDA Approval, Paving Way for $235M Financing

Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and AbbVie. Yuvezzi’s commercialization will be supported by up to $235 million in financing. The post Presbyopia Eye Drop From Startup Tenpoint Gets FDA Approval, Paving Way for $235M Financing…

Read More

Moving Beyond the Mega-Factory: Why the Future of Biomanufacturing is Agile, Distributed, and Resilient

Personalized and highly-targeted therapeutics are becoming more common, making local or regional production increasingly valuable for faster patient access. This underscores how a hybrid network combining large, centralized plants coupled with flexible regional sites will define the next era of resilient biomanufacturing. The post Moving Beyond the Mega-Factory: Why the Future of Biomanufacturing is Agile,…

Read More

The Growing Cost of Medical Bill Collection: How Healthcare Organizations Are Using New AI and Clinical Insights to Improve the Revenue Cycle Management Experience

[Sponsored] A webinar sponsored by Smarter Technologies and moderated by MedCity News Editor-in-Chief Arundhati Parmar included insights on the user experience and benefits from Lakeland Regional Health. The post The Growing Cost of Medical Bill Collection: How Healthcare Organizations Are Using New AI and Clinical Insights to Improve the Revenue Cycle Management Experience appeared first…

Read More